A prospective screening program: current screening and its status.

A prospective screening program: current screening and its status. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

A prospective screening program: current screening and its status. Abstract Text:

A Goldin,J M Venditti,

A prospective screening program: current screening and its status. Publishing Authors By Initials

A Goldin,JM Venditti,

For similar geographic locations: americas: north america: united states research abstracts see: geographic locations: americas: north america: united states research

PUBMED ID PMID:

MEDLINE DATE:

A prospective screening program: current screening and its status. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 76

Page Numbers: 176-91

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1981

A prospective screening program: current screening and its status. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

A prospective screening program: current screening and its status. Keywords Mesh Terms:

KEYWORDS: United States

MESH TERMS: drug therapy

Chemical & Substance for Abstract: A prospective screening program: current screening and its status. Information

Substance Name: Antineoplastic Agents

Registry Number: 0

Grant and Affiliation Information for A prospective screening program: current screening and its status.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

A prospective screening program: current screening and its status Related Publications

• A Dialysis Patient with Bacteremia Caused by a Community-Acquired Methicillin-Resistant Staphylococcus aureus (CA-MRSA) Carrying the Staphylococcal Chromosome Cassette (SCC) mec type V.
• A manual on quantitative drug evaluation in experimental tumor systems.
• A meta-analytic approach to ilioinguinal nerve excision or preservation during open inguinal hernia repair.
• A prospective screening program: current screening and its status.
• Adenoviral-mediated correction of methylmalonyl-CoA mutase deficiency in murine fibroblasts and human hepatocytes.
• Adenovirus-Mediated Gene Delivery Rescues a Neonatal Lethal Murine Model of mut(0) Methylmalonic Acidemia.
• Antileukemic action of reserpine.
• Changes in susceptibilities to teicoplanin, vancomycin and other antibiotics among Staphylococcus aureus isolates in a tertiary-care University hospital.
• Combination radiotherapy and chemotherapy for P388 lymphocytic leukemia in vivo.
• Combination therapy studies with L-asparaginase (NSC-109229) and other antitumor agents.
• Effectiveness of antileukemic agents in mice inoculated with a leukemia L1210 variant resistant to 5-[3,3-bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide (NSC-82196).
• Effectiveness of antileukemic agents in mice inoculated with leukemia L1210 variants resistant to 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) or 5-(3,3-bis(2-chloroethyl)-1-triazeno)imidazole-4-carboxamide (NSC-82196).
• Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943).
• Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromes.
• Immunity of mice surviving systemic leukaemia (L1210) to antifolic resistant variants of the disease.
• In vitro activity of fosfomycin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy.
• Metabolic phenotype of methylmalonic acidemia in mice and humans: the role of skeletal muscle.
• Multidrug-Resistant Acinetobacter baumannii Outbreak in an Intensive Care Unit.
• Observations on a leukemic cell variant in mice.
• Optimal post-remission therapy for flow-cytometry minimal residual disease positive adult patients with acute myeloid leukemia.
• Post-endoscopic polypectomy delayed bleeding concomitant with an abdominoperineal resection: a case report.
• Prediction of the long-term creep behaviour of hydroxyapatite-filled polyethylmethacrylate bone cements.
• Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemia.
• Sequential chemotherapy with cyclophosphamide (NSC-26271) and cytosine arabinoside (NSC-63878) in mice with advanced leukemia L1210.
• The accumulation of reproductive barriers during speciation: postmating barriers in two behaviorally isolated species of darters (Percidae: Etheostoma).
• The efficacy and safety of maintenance ECT in geriatric patients.
• The new NCI screen and its implications for clinical evaluation.
• Upper and lower gastrointestinal diseases in liver transplant candidates.
• Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroe
• Working session report: in vivo-in vitro screening.